Clinical Trials Browser

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Carcinoma, Non-Small-Cell Lung

Uterine Cervical Neoplasms, Renal Insufficiency

Locally Advanced Cervical Cancer

Gallbladder Neoplasms

Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement, Breast Neoplasms

Nasopharyngeal Carcinoma

Neoplastic Cells, Circulating, Pancreatic Neoplasms

Lung Neoplasms

Cholangiocarcinoma

Carcinoma, Non-Small-Cell Lung

Gallbladder Neoplasms

Testicular Neoplasms

Cholangiocarcinoma

Breast Neoplasms, Triple Negative Breast Neoplasms

Uterine Cervical Neoplasms

Lymphoma, Lymphoma, Non-Hodgkin

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

Uterine Cervical Neoplasms

Nasopharyngeal Carcinoma

Pancreatic Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Lung Neoplasms, Small Cell Lung Carcinoma

Lung Neoplasms

Pancreatic Neoplasms

Clinical Trials

IMGeS

Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer

LEDANG

Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease

MICHELE

POLCAGB

First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

PACT-ACT-v6

Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer

Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma

Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV

Adjuvant Chemotherapy vs no Chemotherapy for Patients With GallBllader Carcinoma

Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer

A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection

Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer

CERVIPIB

Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma

Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma

Efficacy Study of Outpatient Therapy for Lymphoma

A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer

Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma

GEMOX-T

Customizing

PGH

PGT

Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer

Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer

Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC

Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer

Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer